transco
- 10 Jun 2004 16:52
Keep an eye on this tech stock - after years of loses, rights issues, etc things look to be moving in the right direction. Tipped by Redmayne last year it could be a winner.
transco
- 22 Apr 2005 17:42
- 38 of 64
Now that would be telling.
ethel
- 22 Apr 2005 17:51
- 39 of 64
Come on,let us share your secret,Transco!
Whatever,the sp is finally moving north.
transco
- 25 Apr 2005 18:06
- 40 of 64
Just read my earlier posts last year and read between the lines.
This is a top class business, building a long term sound future.
transco
- 15 Jun 2005 18:11
- 41 of 64
Its time for protherics to fly !!!!!!!!!!!
transco
- 16 Jun 2005 18:18
- 42 of 64
well still it goes up and up... takeover talk about and discounted rights issue
transco
- 21 Jun 2005 18:12
- 43 of 64
up on a bad day - plus good volume.
transco
- 28 Jun 2005 06:51
- 44 of 64
Has nobody noticed this move!!
Come on chaps credit where its due.
What a mover!!! and more to come...
queen1
- 09 Jan 2006 13:23
- 45 of 64
Transco - are you still in? I've taken the plunge today. Downside seems limited whilst upside potential is superb. Fingers crossed.
hlyeo98
- 20 Jan 2006 15:16
- 46 of 64
Protherics PLC
12 January 2006
CYTOFABTM LICENSING AGREEMENT BETWEEN PROTHERICS AND ASTRAZENECA BECOMES
EFFECTIVE FOLLOWING HART-SCOTT-RODINO CLEARANCE
London, UK, Nashville, TN, 12 January 2006 - Following the announcement on 8
December 2005, of the licensing agreement between Protherics and AstraZeneca for
the global development and commercialisation of Protherics' anti-sepsis product
CytoFabTM, it is further announced that the agreement has become effective
following the expiry of the Hart-Scott-Rodino waiting period in the US.
This triggers an immediate initial payment to Protherics of 16.3 million and a
7.5 million equity investment by AstraZeneca in Protherics. The agreement has
further potential milestone payments worth up to 171 million and Protherics
will also receive a 20 percent net royalty on the net global sales of CytoFabTM.
hlyeo98
- 20 Jan 2006 15:18
- 47 of 64
Protherics PLC
20 January 2006
PROTHERICS PLC
NOTIFICATION OF MAJOR INTERESTS IN SHARES
20 January 2005: Protherics PLC (the 'Company'), the biopharmaceutical company
focused on critical care and oncology, received notification today from
Perpetual Income & Growth Investment Trust plc on behalf of INVESCO Asset
Management Limited that Perpetual Income & Growth Investment Trust plc is the
beneficial owner of 10,115,137 ordinary shares representing 3.92% of the issued
share capital of the Company.
This notification follows an increase in the Company's issued share capital to
258,328,129 ordinary shares.
hlyeo98
- 20 Jan 2006 15:18
- 48 of 64
Protherics PLC
20 January 2006
PROTHERICS PLC
NOTIFICATION OF MAJOR INTERESTS IN SHARES
20 January 2006: Protherics PLC, the biopharmaceutical company focused on
critical care and oncology (the 'Company'), received notification on 19 January
2006 from Aviva plc that, as at 18 January 2006, Aviva plc and its subsidiaries
held a beneficial interest in 12,383,731 ordinary shares, representing 4.79% of
the issued share capital of the Company, and a total interest in 27,603,457
ordinary shares, representing 10.68% of the issued share capital of the Company.
This notification follows an increase in the Company's issued share capital to
258,328,129 ordinary shares.
hlyeo98
- 20 Jan 2006 15:19
- 49 of 64
Protherics PLC
20 January 2006
PROTHERICS PLC
NOTIFICATION OF MAJOR INTERESTS IN SHARES
20 January 2005: Protherics PLC (the 'Company'), the biopharmaceutical company
focused on critical care and oncology, received notification on 19 January 2006
from AXA Investment Managers UK Limited on behalf of AXA S.A. and its Group
Company ('AXA S.A.') that, on 18 January 2006, AXA S.A. held an interest in
32,099,803 ordinary 2p shares (the 'Shares') in the share capital of the Company
(12.43%).
The Shares are represented by a beneficial interest in 10,000 ordinary shares
(0.004%) and a non-beneficial interest in 32,089,803 ordinary shares (12.422%).
This notification follows an increase in the Company's issued share capital to
258,328,129 ordinary shares.
queen1
- 20 Jan 2006 23:02
- 50 of 64
Lots of splendid news hlyeo98. I especially like the "The agreement has
further potential milestone payments worth up to 171 million and Protherics
will also receive a 20 percent net royalty on the net global sales of CytoFabTM", piece!
hlyeo98
- 24 Jan 2006 17:44
- 51 of 64
There is also a positive article on PTI in the Shares Magazine this week
queen1
- 24 Jan 2006 22:32
- 52 of 64
Indeed - good day today as well. Break 1 tomorrow me thinks.
greekman
- 25 Jan 2006 10:51
- 53 of 64
q1,
Well at present your pediction is wrong. This is not a dig, as I also thought it would break the 1 line. All the indications were looking like a plus 1 today but I suppose there is most of the trading day left. It just shows how volatile share dealing can be. Still I now expect a few small adjustments till we get some news.
hlyeo98
- 25 Jan 2006 12:16
- 54 of 64
There was huge selling yesterday of 2 blocks of more than 1,000,000 each.
queen1
- 25 Jan 2006 14:12
- 55 of 64
greekman - no dig assumed but it did break 1 today, it just didn't stay there...
greekman
- 25 Jan 2006 15:36
- 56 of 64
L2 looking good. 2 on the bid, against 8 on the ask. If the next 3 Set's on the bid go, I would expect it to end up a bit better that the present price of 2.5p down.
greekman
- 25 Jan 2006 16:37
- 57 of 64
I give in trying to read this share.